Related references
Note: Only part of the references are listed.Autoreactive-Aβ antibodies promote APP β-secretase processing
Juan Deng et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
Reisa Sperling et al.
LANCET NEUROLOGY (2012)
Revised criteria for diagnosis of Alzheimer's disease: National Institute on Aging-Alzheimer's Association diagnostic guidelines for Alzheimer's disease
Zaven S. Khachaturian
ALZHEIMERS & DEMENTIA (2011)
Amyloid-Dependent and Amyloid-Independent Stages of Alzheimer Disease
Bradley T. Hyman
ARCHIVES OF NEUROLOGY (2011)
Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers
William D. Knight et al.
BRAIN (2011)
Naturally Occurring Autoantibodies against β-Amyloid: Investigating Their Role in Transgenic Animal and In Vitro Models of Alzheimer's Disease
Richard Dodel et al.
JOURNAL OF NEUROSCIENCE (2011)
p75NTR Regulates Aβ Deposition by Increasing Aβ Production But Inhibiting Aβ Aggregation with Its Extracellular Domain
Yan-Jiang Wang et al.
JOURNAL OF NEUROSCIENCE (2011)
Molecular basis for amyloid-β polymorphism
Jacques-Philippe Colletier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Immune responsiveness to inhaled antigens: local antibody production in the respiratory tract in health and lung diseases
Y. YOSHIZAWA et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Conformations and Biological Activities of Amyloid Beta Peptide 25-35
L. Millucci et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2010)
Modified Immunotherapies Against Alzheimer's Disease: Toward Safer and Effective Amyloid-beta Clearance
Yan-Jiang Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Generation and Therapeutic Efficacy of Highly Oligomer-Specific β-Amyloid Antibodies
Heinz Hillen et al.
JOURNAL OF NEUROSCIENCE (2010)
Can Alzheimer disease be prevented by amyloid-β immunotherapy?
Cynthia A. Lemere et al.
NATURE REVIEWS NEUROLOGY (2010)
Anti-ADDL antibodies differentially block oligomer binding to hippocampal neurons
P. J. Shughrue et al.
NEUROBIOLOGY OF AGING (2010)
Aβ Immunotherapy: Intracerebral Sequestration of Aβ by an Anti-Aβ Monoclonal Antibody 266 with High Affinity to Soluble Aβ
Kaoru Yamada et al.
JOURNAL OF NEUROSCIENCE (2009)
APOE ε4 and bapineuzumab Infusing pharmacogenomics into Alzheimer disease therapeutics
Dan Kaufer et al.
NEUROLOGY (2009)
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
S. Salloway et al.
NEUROLOGY (2009)
P4-346: Safety, tolerability and biomarker effects of an Abeta monoclonal antibody administered to patients with Alzheimer's disease
Eric R. Siemers et al.
Alzheimers & Dementia (2008)
Consequence of A immunization on the vasculature of human Alzheimers disease brain
D. Boche et al.
BRAIN (2008)
Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease
Masayoshi Takeuchi et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Inflammaging as a prodrome to Alzheimer's disease
Brian Giunta et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Immunotherapy reduces vascular amyloid-β in PDAPP mice
Sally Schroeter et al.
JOURNAL OF NEUROSCIENCE (2008)
Long-term effects of Aβ42 immunisation in Alzheimer's disease:: follow-up of a randomised, placebo-controlled phase I trial
Clive Holmes et al.
LANCET (2008)
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Ganesh M. Shankar et al.
NATURE MEDICINE (2008)
Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease
Roy O. Weller et al.
BRAIN PATHOLOGY (2008)
Alzheimer's disease peptide epitope vaccine reduces insoluble but not soluble/oligomeric Aβ species in amyloid precursor protein transgenic mice
Irina Petrushina et al.
JOURNAL OF NEUROSCIENCE (2007)
Amyloid-β peptide remnants in AN-1792-immunized Alzheimer's disease patients -: A biochemical analysis
R. Lyle Patton et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Effects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease
NC Fox et al.
NEUROLOGY (2005)
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
S Gilman et al.
NEUROLOGY (2005)
Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor proteintransgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid β
MM Racke et al.
JOURNAL OF NEUROSCIENCE (2005)
A beta 42 immunization in Alzheimer's disease generates A beta N-terminal antibodies
M Lee et al.
ANNALS OF NEUROLOGY (2005)
Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease
I Ferrer et al.
BRAIN PATHOLOGY (2004)
Human anti-β-amyloid antibodies block β-amyloid fibril formation and prevent β-amyloid-induced neurotoxicity
YS Du et al.
BRAIN (2003)
Increased T cell reactivity to amyloid β protein in older humans and patients with Alzheimer disease
A Monsonego et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide:: a case report
JAR Nicoll et al.
NATURE MEDICINE (2003)
Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
KN Dahlgren et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Immune hyporesponsiveness to amyloid β-peptide in amyloid precursor protein transgenic mice:: Implications for the pathogenesis and treatment of Alzheimer's disease
A Monsonego et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
